2023-2024 Regular SessionUS Congress Legislature

HB6227: Adding Coccidioidomycosis to the FDA Priority Review Voucher Program Act of 2023

Legislative Summary

To amend the Federal Food, Drug, and Cosmetic Act to expand the tropical disease product priority review voucher program to encourage prevention and treatment of coccidioidomycosis.

Bill History

11/3/2023
Introduced in House
House of Representatives
11/3/2023
Referred to the House Committee on Energy and Commerce.
House of Representatives
11/10/2023
Referred to the Subcommittee on Health.
House of Representatives